| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/15/2005 | US20050203047 Methods for transcription and expression of nucleic acids into organisms; in particular, invention comprises a tRNA vector system to deliver and express short interfering nucleic acid, small interfering (siRNA), micro RNA (miRNA) and antisense (asRNA) into organism with high efficiency; pain treatment |
| 09/15/2005 | US20050203045 Antisense modulation of cellular inhibitor of Apoptosis-2 expression |
| 09/15/2005 | US20050203044 Small-mer having about 3 to about 6 nucleotides and having antiviral or antiproliferative activity or both; useful in therapeutic, diagnostic, target validation, and genomic discovery applications; capable of inhibiting viral replication |
| 09/15/2005 | US20050203043 Identification of toxic nucleotide sequences |
| 09/15/2005 | US20050203042 Oligomeric compounds for the modulation of Bcl-2 |
| 09/15/2005 | US20050203041 Antisense compound and method for selectively killing activated T cells |
| 09/15/2005 | US20050203040 siNA molecule comprising a double-stranded structure that down-regulates expression of vascular cell adhesion molecule (VCAM), wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 09/15/2005 | US20050203038 Modulation of ACE2 expression |
| 09/15/2005 | US20050203026 Rosacea; vascular endothelial growth factor inhibitors; protease inhibitors such as Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor |
| 09/15/2005 | US20050203009 Inhibiting VPAC1 (Vasoactive intestinal peptide)-mediated tumorigenesis; inhibits binding of pituitary adenylate cyclase-activating polypeptide (PACAP) to cell membranes |
| 09/15/2005 | US20050203007 Eglin c based drugs for treatment of disease |
| 09/15/2005 | US20050202565 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence |
| 09/15/2005 | US20050202552 Proteins producing an altered immunogenic response and methods of making and using the same |
| 09/15/2005 | US20050202551 Proteins producing an altered immunogenic response and methods of making and using the same |
| 09/15/2005 | US20050202547 Allows the above microorganism to use cyclododecanol and cyclododecanone (12-membered ring compounds) as sole carbon source for growth and energy |
| 09/15/2005 | US20050202537 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 09/15/2005 | US20050202535 Fusion protein comprising bowman-kirk, soybean trypsin and eglin C inhibitors for use in treatment and prevention of inflammatory, arthritic and skin disorders |
| 09/15/2005 | US20050202532 Amino acid sequences for prevention and treatment of cardiovascular disease |
| 09/15/2005 | US20050202531 Receptor protein for identifying modulators to treat and prevent inflammatory, antherosclerotic and cancer disorders; wound healing agents |
| 09/15/2005 | US20050202528 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof |
| 09/15/2005 | US20050202526 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202519 Mutated abl kinase domains |
| 09/15/2005 | US20050202503 Displacement assay for detection of small molecules |
| 09/15/2005 | US20050202501 Using sequencing by hybridization as tool in detecting variance in genic sequences; identifying restriction fragment length polymorphism and/or single nucleotide polymorphisms |
| 09/15/2005 | US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/15/2005 | US20050202480 Stabilization of linear double-stranded DNA in the presence of exonucleases |
| 09/15/2005 | US20050202479 Methods and materials relating to insulin growth factor-like (IGFL) polypeptides and polynucleotides |
| 09/15/2005 | US20050202477 Nucleic acid probe for use in screening and identifying grampositive bacteria |
| 09/15/2005 | US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders |
| 09/15/2005 | US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders |
| 09/15/2005 | US20050202460 Methods and compositions for detecting Bacillus species |
| 09/15/2005 | US20050202459 Non-natural polynucleotide formed via fluid comprising template and intercalator, and ligating |
| 09/15/2005 | US20050202456 Processes for detecting or quantifying analytes of interest |
| 09/15/2005 | US20050202455 Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library |
| 09/15/2005 | US20050202450 Polypeptides stable under hypoxic and nonhypoxic conditions; antihypoxic agents; myocardial necrosis and arrhythmia, strokes, autoimmune deseases, neurodegenerative disorders |
| 09/15/2005 | US20050202443 Type II restriction endonuclease and application thereof |
| 09/15/2005 | US20050202441 Methods of designing, synthesizing, and propagating reference nucleic acids |
| 09/15/2005 | US20050202437 Expression vector comprised of lactobacillus and heterologous gene sequences for use as gene therapeutic tools; enhancing expression of exogenous gene sequences |
| 09/15/2005 | US20050202436 Target-specific multiple sequencing primer pool for microbial typing and sequencing applications in DNA-sequencing technologies |
| 09/15/2005 | US20050202432 Plurality of genes differentially expressed in kidney cells after exposure to hormone; identifying agents which enhance calcium uptake in post-menopausal women; diagnosing and treating cardiovascular disorders |
| 09/15/2005 | US20050202424 Membrane protein for use as tool in identifying modulators for treatment of phenotype-mediated antibiotic-resistance; microbiocides; bactericides; preventing infection in cystic fibrosis patients |
| 09/15/2005 | US20050202419 Peroxide-driven cytochrome P450 oxygenase variants |
| 09/15/2005 | US20050202417 Oligonucleotide probe for determining concentration of viral genomes in biological fluids |
| 09/15/2005 | US20050202416 Gene-specific polynucleotide primers for identifying coronavirus particles in biological fluids |
| 09/15/2005 | US20050202396 Microarray with increased flexibility for use in gene expression analysis |
| 09/15/2005 | US20050202077 Targeted delivery of RNA interference molecules |
| 09/15/2005 | US20050202022 Polynucleotides encoding humanized antibodies against human 4-1BB |
| 09/15/2005 | US20050202021 Anti-cancer antibodies with reduced complement fixation |
| 09/15/2005 | US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 09/15/2005 | US20050201976 Selective inhibitors of nuclear factor-kappaB activation and uses thereof |
| 09/15/2005 | US20050201975 Modifying chemokine G-protein mediated signalling and/or signal transduction by administering a modulator of the Notch signalling pathway; using a fusion protein of a segment of a Notch ligand extracellular domain and an immunoglobulin Fc segment or a polynucleotide encoding it; antiinflammatory agents |
| 09/15/2005 | US20050201937 Creation of a gradient of isotope enrichment; ability to measure a multiplicity of isotope enrichments simultaneously |
| 09/15/2005 | DE102004009704A1 New conjugates useful for labeling nucleic acids comprise a label coupled to nucleotide or nucleoside molecules through polymer linkers |
| 09/15/2005 | CA2560066A1 Natural igm antibodies and inhibitors thereof |
| 09/15/2005 | CA2559114A1 Compounds for hydrolysing ribonucleic acids (rnas) |
| 09/15/2005 | CA2558960A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 09/15/2005 | CA2558667A1 Antisense oligonucleotides for inhibiting the formation of metastases in cancer |
| 09/15/2005 | CA2558510A1 Thrombomodulin (thbd) haplotypes predict outcome of patients |
| 09/15/2005 | CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 09/15/2005 | CA2557818A1 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry |
| 09/15/2005 | CA2557661A1 Nucleic acid complexes |
| 09/15/2005 | CA2557571A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 09/15/2005 | CA2557353A1 Immunogenic compositions for chlamydia pneunomiae |
| 09/14/2005 | EP1574577A2 Growth differentiation factor-11 |
| 09/14/2005 | EP1574572A1 Compounds for hydrolysing ribonucleic acids (RNAs) |
| 09/14/2005 | EP1573070A2 pRNA CHIMERA |
| 09/14/2005 | EP1573065A2 Methods for rapid forensic analysis of mitochondrial dna and characterizationg of mitochondrial dna heteroplasmy |
| 09/14/2005 | EP1573045A2 Heart failure gene determination and therapeutic screening |
| 09/14/2005 | EP1573038A2 A high resolution typing system for pathogenic mycobacterium tuberculosum |
| 09/14/2005 | EP1573036A2 Subtelomeric dna probes and method of producing the same |
| 09/14/2005 | EP1573035A2 Brother of the regulator of imprinted sites (boris) |
| 09/14/2005 | EP1573031A2 Androgen regulated nucleic acid molecules and encoded proteins |
| 09/14/2005 | EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 09/14/2005 | EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 09/14/2005 | EP1573009A2 Detection of small nucleic acids |
| 09/14/2005 | EP1572987A2 Novel nucleic acids and polypeptides |
| 09/14/2005 | EP1572978A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 09/14/2005 | EP1572977A2 Assay and compositions for detection of bacillus anthracis nucleic acid |
| 09/14/2005 | EP1572975A2 Streptococcus uberis adhesion molecule |
| 09/14/2005 | EP1572970A2 Inhibitory oliogonucleotides targeted to bcl-2 |
| 09/14/2005 | EP1572967A2 Il-1 receptor based antagonists and methods of making and using |
| 09/14/2005 | EP1572965A2 Human sarcoma-associated antigens |
| 09/14/2005 | EP1572964A2 Double-stranded rna structures and constructs, and methods for generating and using the same |
| 09/14/2005 | EP1572960A2 Identification of a novel bitter taste receptor, t2r76 |
| 09/14/2005 | EP1572953A2 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 |
| 09/14/2005 | EP1572952A2 Novel polynucleotide and polypeptide sequences and uses thereof |
| 09/14/2005 | EP1572941A2 Novel flavivirus antigens |
| 09/14/2005 | EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon |
| 09/14/2005 | EP1572929A2 Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes |
| 09/14/2005 | EP1572925A2 Cancer-linked gene as target for chemotherapy |
| 09/14/2005 | EP1572924A2 Contraceptive targets |
| 09/14/2005 | EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/14/2005 | EP1572921A2 Cytokine polypeptides |
| 09/14/2005 | EP1572908A2 Chimeric molecules for cleavage in a treated host |
| 09/14/2005 | EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
| 09/14/2005 | EP1572906A2 Novel nucleic acid molecules and polypeptides encoding baboon tafi |
| 09/14/2005 | EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 09/14/2005 | EP1572886A2 Use of phosphorothiolate polynucleotides in ligating nucleic acids |
| 09/14/2005 | EP1572878A2 Compositions and methods for inferring a response to a statin |
| 09/14/2005 | EP1572875A2 Receptors and membrane-associated proteins |